Valacyclovir compared with acyclovir for the treatment of herpes zoster ophthalmicus in people


There is uncertainty as to the benefits and harms of valacyclovir compared with acyclovir for the treatment of herpes zoster ophthalmicus.

What was studied in the review?

Herpes zoster ophthalmicus is a painful itchy rash that appears on one side of the forehead. If the rash reaches the eye it may lead to visual impairment. This is because the infection can damage the front of the eye. Herpes zoster is caused by the chickenpox virus, which can remain in the body for many years after the original chickenpox infection, and may get reactivated. Doctors can treat herpes zoster ophthalmicus with acyclovir. This is an antiviral medication that kills the chickenpox virus. Valacyclovir is a modified version of acyclovir that may need to be taken less frequently as it is better absorbed by the body.

What are the main results of the review?

The review authors found one relevant study from France. This study compared valacyclovir 1000 mg taken three times a day for seven days with acyclovir 800 mg taken five times a day for seven days. The company that makes valacyclovir (Glaxo) funded the study.

The review authors are uncertain whether valacyclovir has any benefit over acyclovir in the treatment of herpes zoster ophthalmicus. They judged the certainty of the evidence to be very low because the study was small and there were some problems with the way it was reported.

How up to date is this review?

The Cochrane researchers searched for studies that had been published up to June 2016.
Abstract

Background: Herpes zoster ophthalmicus affects the eye and vision, and is caused by the reactivation of the varicella zoster virus in the distribution of the first division of the trigeminal nerve. An aggressive management of acute herpes zoster ophthalmicus with systemic antiviral medication is generally recommended as the standard first line treatment for herpes zoster ophthalmicus infections. Both acyclovir and its prodrug valacyclovir are medications that are approved for the systemic treatment of herpes zoster. Although it is known that valacyclovir has an improved bioavailability and steadier plasma concentration, it is currently unclear as to whether this leads to better treatment results and less ocular complications.

Objectives: To assess the effects of valacyclovir versus acyclovir for the systemic antiviral treatment of herpes zoster ophthalmicus in immunocompetent patients.

Search methods: We searched CENTRAL (which contains the Cochrane Eyes and Vision Trials Register; 2016, Issue 5), Ovid MEDLINE, Ovid MEDLINE In Process and Other Non Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to June 2016), Embase (January 1980 to June 2016), Web of Science Conference Proceedings Citation Index Science (CPCI S; January 1990 to June 2016), BIOSIS Previews (January 1969 to June 2016), the ISRCTN registry (www.isrctn.com/editAdvancedSearch), ClinicalTrials.gov (www.clinicaltrials.gov), and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP; www.who.int/ictrp/search/en). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 13 June 2016.

Selection criteria: We considered all randomised controlled trials (RCTs) in which systemic valacyclovir was compared to systemic acyclovir medication for treatment of herpes zoster ophthalmicus. There were no language restrictions.

Data collection and analysis: Two review authors independently selected trials, evaluated the risk of bias in included trials, and extracted and analysed data. We did not conduct a meta analysis, as only one study was included. We assessed the certainty of the evidence for the selected outcomes using the GRADE approach.

Main results: One study fulfilled the inclusion criteria. In this multicentre, randomised double masked study carried out in France, 110 immunocompetent people with herpes zoster ophthalmicus, diagnosed within 72 hours of skin eruption, were treated, with 56 participants allocated to the valacyclovir group and 54 to the acyclovir group. The study was poorly reported and we judged it to be unclear risk of bias for most domains.

Persistent ocular lesions after 6 months were observed in 2/56 people in the valacyclovir group compared with 1/54 people in the acyclovir group (risk ratio (RR) 1.93 (95% CI 0.18 to 20.65); very low certainty evidence. Dendritic ulcer appeared in 3/56 patients treated with valacyclovir, while 1/54 suffered in the acyclovir group (RR 2.89; 95% confidence interval (CI) 0.31 to 26.96); very low certainty evidence), uveitis in 7/56 people in the valacyclovir group compared with 9/54 in the acyclovir group (RR 0.96; 95% CI 0.36 to 2.57); very low certainty evidence). Similarly, there was uncertainty as to the comparative effects of these two treatments on post herpetic pain, and side effects (vomiting, eyelid or facial edema, disseminated zoster). Due to concerns about imprecision (small number of events and large confidence intervals) and study limitations, the certainty of evidence using the GRADE approach was rated as low to very low for the use of valacyclovir compared to acyclovir.

Authors' conclusions: This review included data from only one study, which had methodological limitations. As such, our results indicated uncertainty of the relative benefits and harms of valacyclovir over acyclovir in herpes zoster ophthalmicus, despite its widespread use for this condition. Further well designed and adequately powered trials are needed. These trials should include outcomes important to patients, including compliance.

Editorial Group: Cochrane Eyes and Vision Group.

Publication status: New.

Citation: Schuster AK, Harder BC, Schlichtenbrede FC, Jarczok MN, Tesarz J. Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients. Cochrane Database of Systematic Reviews 2016, Issue 11. Art. No.: CD011503. DOI: 10.1002/14651858.CD011503.pub2.


Source: https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0089861/

Saturday, May 30, 2026

Tizanidine (Zanaflex) - Muscle Relaxants - Patient guide - Quick tips

Tizanidine can be useful for painful muscle tightness, but over-the-counter add-ons need careful selection because sedation and blood pressure effects already exist. Safe support plan focuses on reducing triggers and avoiding central nervous system depressant stacking. Most common mistake is combining tizanidine with sedating OTC antihistamines or nighttime cold products. This can worsen dizziness, confusion, and fall risk, especially in older adults or patients taking additional sedating medicines. Hydration, regular meals, and gradual mobility work are high-value supports. Dehydration and sudden position changes can amplify hypotension symptoms in some users, so daily routine stability matters. Heat therapy, targeted stretching, and posture correction can reduce spasm recurrence and lower need for extra medication. These non-drug supports often improve daytime function more than adding random rescue products. These points explain why over the counter options combined with tizanidine therapy should be reviewed with pharmacist or clinician and documented on one medication list. Ingredient overlap and sedative burden should be checked before every new OTC purchase. Warning signs should not be masked with more products. Near-syncope, persistent lightheadedness, severe weakness, confusion, breathing concerns, or repeated falls need prompt reassessment. Caregivers can help by separating daytime and nighttime products, checking labels, and supporting slower position changes when hypotension risk is present. Patients should keep symptom diary including dose time, dizziness episodes, sleep quality, and function gains. This helps clinicians adjust schedule safely. If spasm control remains poor despite cautious use, care plan should shift toward reassessment and rehabilitation optimization rather than sedative escalation. For broader guidance on safe spasm-management combinations and recovery planning, patients can review muscle relaxants care resources before follow-up visits. Simple household checklist with allowed products, prohibited sedative combinations, and emergency contact steps improves safety during nighttime flare events. Preparation reduces preventable medication errors. Consistency keeps outcomes more stable.

Wednesday, May 27, 2026

Understanding High Cholesterol and Online Care

High cholesterol, or hyperlipidemia, is one of the most common risk factors for cardiovascular disease. Elevated levels of low-density lipoprotein cholesterol, often called bad cholesterol, contribute to the buildup of plaques in artery walls, increasing the risk of heart attack, stroke, and peripheral vascular disease. Most people with high cholesterol have no symptoms, making regular screening and ongoing management essential. Cholesterol levels are measured through a blood test called a lipid panel. This test measures total cholesterol, LDL cholesterol, high-density lipoprotein or good cholesterol, and triglycerides. Healthcare providers use these values along with other cardiovascular risk factors such as age, smoking status, blood pressure, and diabetes status to calculate a patient's overall cardiovascular risk and determine appropriate treatment targets. Telehealth is well-suited for managing high cholesterol once a diagnosis has been established and a treatment plan is in place. Virtual visits can be used to review lab results, discuss dietary changes, address questions about statin medications, and manage side effects. Patients on statin therapy who develop muscle pain or weakness can report this to their provider during a telehealth visit and have their medication adjusted or switched. For patients needing pharmacy services alongside cholesterol management, https://www.amoxilcompharm.com/ offers convenient prescription support. Lifestyle changes are the foundation of cholesterol management. Reducing intake of saturated and trans fats, increasing dietary fiber through fruits, vegetables, and whole grains, increasing physical activity, and achieving a healthy weight all contribute to improving cholesterol levels. For patients whose cholesterol does not reach target levels with lifestyle changes alone, medication therapy with statins or other lipid-lowering drugs is recommended. Regular monitoring is important for patients on cholesterol-lowering therapy to assess treatment response and watch for side effects. Lipid panels are typically repeated four to twelve weeks after starting or changing therapy, and then annually once levels are stable. Liver function tests may be monitored in patients on certain medications. For comprehensive information on cholesterol management and telehealth resources, visit https://amoxicillina.online/ for evidence-based patient health education.

Saturday, May 16, 2026

Seroquel: Side Effects, Drug Interactions, And Precautions

Every medication carries the potential for side effects, and Seroquel (quetiapine) is no exception. Understanding what side effects are possible, which are common versus rare, and what warning signs warrant medical attention allows patients to use the medication safely and confidently. Most people who take Seroquel as directed tolerate it without major problems, but individual responses vary. First-generation antipsychotics, developed in the 1950s, work primarily by blocking dopamine D2 receptors in the brain. While effective for positive symptoms of psychosis such as hallucinations and delusions, they carry a significant risk of extrapyramidal side effects including drug-induced Parkinsonism, akathisia, and tardive dyskinesia. Second-generation atypical antipsychotics block both dopamine and serotonin receptors, typically causing fewer movement-related side effects while introducing other concerns such as metabolic effects including weight gain and elevated blood sugar. The most frequently reported side effects of quetiapine are typically mild and often resolve within days to weeks as the body adjusts. Serious side effects occur less frequently but are documented in prescribing information and patient safety guides. Complete side effect information and precautions are listed at https://mednewwsstoday.com/antipsychotics/seroquel-quetiapine/, which serves as a reliable reference for anyone beginning therapy with Seroquel or monitoring an ongoing treatment. Drug interactions are an important safety consideration for any medication. Seroquel may interact with other prescription drugs, over-the-counter medications, supplements, or certain foods, affecting how it is metabolized or how effective it is. A pharmacist or doctor can review a patient's full medication list to identify any clinically significant interactions before starting Seroquel. Patients should also avoid making changes to their medication regimen without first consulting a healthcare professional. More information on medications used in antipsychotic medications and how they compare in terms of safety and efficacy is available through the resource at antipsychotic medications. Staying informed helps patients participate actively in decisions about their care.

Wednesday, May 13, 2026

How Doxazosin Helps With Sleep

Dealing with sleep can take a real toll on daily life, affecting sleep, work performance, and overall well-being. While many people try to manage symptoms with lifestyle adjustments alone, medication often plays a central role in achieving meaningful relief, particularly when symptoms are moderate to severe or recurring. Antihypertensive medications work through several different mechanisms, and many patients eventually require two or more drugs to achieve adequate blood pressure control. Major classes include ACE inhibitors and ARBs, which relax blood vessels by blocking the renin-angiotensin system; calcium channel blockers, which reduce arterial stiffness; beta-blockers, which slow the heart rate and reduce its workload; and diuretics, which reduce blood volume by increasing fluid excretion through the kidneys. Healthcare professionals frequently discuss Doxazosin as a potential treatment for patients presenting with sleep. The data supporting doxazosin for sleep provides a useful resource for patients who want a thorough understanding of how this medication has been studied and what clinical experience suggests about its effectiveness. One of the practical considerations with Doxazosin is timing. Some patients find that taking the medication at a consistent time each day helps maintain stable effects. Food interactions, if any, should be noted since they can affect how well the active ingredient doxazosin is absorbed. Patients are encouraged to review the full prescribing information or consult a pharmacist for personalized guidance. Treatment of sleep does not always follow a one-size-fits-all approach. The https://mednewwsstoday.com/blood-pressure/ section on blood pressure management covers the range of treatments that might complement or serve as alternatives to Doxazosin, helping patients and providers find the combination most suited to individual needs.

Sunday, May 10, 2026

Lasix: Brand Name Medication Guide For Diuretics And Fluid Balance

Lasix is the brand name for furosemide, a medication used in the management of conditions associated with diuretics and fluid balance. Brand name medications are pharmaceutical products marketed under a proprietary name by the company that originally developed them. Understanding the relationship between brand name and generic formulations, as well as the conditions for which the medication is approved, helps patients make informed choices about their treatment. There are three main classes of diuretics used clinically: thiazide diuretics, loop diuretics, and potassium-sparing diuretics. Thiazide diuretics like hydrochlorothiazide are mild and are commonly used as first-line treatment for hypertension. Loop diuretics like furosemide are more potent and are used when stronger diuresis is needed, as in heart failure. Potassium-sparing diuretics prevent the potassium loss that other diuretics cause and are often combined with thiazides or loops for this reason. The brand name Lasix has built a clinical track record through use in a wide range of patients and healthcare settings. Brand versions and their generic equivalents contain the same active ingredient at the same strength, but may differ in inactive ingredients such as fillers, binders, and coatings. In most cases, generic formulations are therapeutically equivalent and offer cost savings, though some patients prefer to stay on a specific formulation for consistency. When prescribed Lasix, patients should follow the guidance of their prescribing physician regarding dose, frequency, and duration of therapy. The medication should be stored as directed on the label, typically at room temperature away from heat and moisture. Any unused medication should not be disposed of by flushing down the drain unless the label specifically says to do so, as this can harm the environment. Comprehensive details on Lasix and other medications used for diuretics and fluid balance are available through diuretics and fluid balance. This resource provides evidence-based summaries to help patients and healthcare providers stay informed about treatment options in this therapeutic area.

Tuesday, May 5, 2026

Bupropion: The Generic Form Of Wellbutrin Explained

Bupropion is the generic name of the medication sold under the brand name Wellbutrin. Generic medications contain the same active ingredient at the same dose and strength as their brand name counterparts and must meet the same FDA standards for quality, purity, and bioequivalence. The development and approval of generic drugs play an important role in making effective treatments more accessible and affordable for patients. Antidepressant medications have been central to depression treatment for decades. The first antidepressants developed, the monoamine oxidase inhibitors and tricyclic antidepressants, were effective but had significant side effect profiles that limited their use. The introduction of selective serotonin reuptake inhibitors in the 1980s represented a major advance, offering comparable efficacy with substantially improved tolerability. Today there are multiple antidepressant classes available, allowing treatment to be tailored to the individual patient's needs and tolerability. The pharmacological action of bupropion is the basis for its use in treating conditions within the category of antidepressant medications. Understanding the mechanism by which the active compound produces its therapeutic effects helps patients appreciate why the medication needs to be taken consistently and at the correct dose to achieve the best results. Switching between brand name and generic versions of a medication is generally considered safe when the products are bioequivalent, but patients should inform their doctor if they notice any differences in effect after a formulary change. Some patients with conditions requiring precise drug levels in the blood may be monitored more closely during transitions. For most patients, however, approved generics provide equivalent therapeutic benefit to the brand name product. The https://mednewwsstoday.com/antidepressants/ section on antidepressant medications covers both brand name and generic treatment options, giving patients a complete picture of what is available. Cost, insurance coverage, and pharmacy availability are practical factors to discuss with a pharmacist when filling a prescription for bupropion.